Press Releases
-
DaVita Clinical Research Study Indicates Effectiveness of mRNA COVID-19 Vaccines in Dialysis Patients
Dialysis patients who received mRNA COVID-19 vaccines had a lower risk of COVID-19 diagnosis post-vaccination and were less likely to be hospitalized or die following breakthrough infection than...
-
DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2021
DaVita Clinical Research (DCR) will present eight research abstracts from company representatives and medical professionals during the American Society of Nephrology (ASN) Kidney Week occurring...
-
The American Diabetes Association® and DaVita Raise Awareness about the Link between Diabetes and Kidney Disease during American Diabetes Month®
In honor of American Diabetes Month® (ADM), the American Diabetes Association® (ADA) and DaVita are coming together to educate Americans about the connection between diabetes and kidney disease....
-
DaVita Inc. 3rd Quarter 2021 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2021. "The third quarter was another strong quarter for DaVita in the face of a challenging...
-
DaVita Inc. Schedules Virtual Capital Markets Day for November 16, 2021
DaVita Inc. (NYSE: DVA), announced today that it will host a virtual Capital Markets Day on Tuesday, November 16, 2021, from 10:00 a.m. to 12:00 p.m. Eastern Time. A direct link to the webcast is:...